Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia
Yang Liu, Yue Dai, Qing Li, et al.
Neuroscience Letters (2020) Vol. 736, pp. 135279-135279
Closed Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
Liudmila Andreeva, Liron David, Shaun Rawson, et al.
Cell (2021) Vol. 184, Iss. 26, pp. 6299-6312.e22
Open Access | Times Cited: 187
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Tao Liang, Yang Zhang, Suyuan Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 126
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 111
Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice
Jing Sun, Yuhe Zhang, Yu Kong, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 76-88
Open Access | Times Cited: 102
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Yawen Cai, Yuhui Chai, Yu Fu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 90
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 58
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Role of pyroptosis in the pathogenesis of various neurological diseases
Abiola Oladapo, Thomas L. Jackson, Jueliet Menolascino, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 428-446
Closed Access | Times Cited: 28
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease
Yinghong Li, Ying Han, Qi Shu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117814-117814
Open Access | Times Cited: 2
Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 15
Open Access | Times Cited: 91
NLRP3 inflammasome in neurodegenerative disease
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67
Pyroptosis, and its Role in Central Nervous System Disease
Yingchao Hu, Bingwei Wang, Sheng Li, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 4, pp. 167379-167379
Closed Access | Times Cited: 66
Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, et al.
Nutrition Research (2022) Vol. 107, pp. 96-116
Open Access | Times Cited: 51
Neuroprotective Effects of Phytochemicals against Aluminum Chloride-Induced Alzheimer’s Disease through ApoE4/LRP1, Wnt3/β-Catenin/GSK3β, and TLR4/NLRP3 Pathways with Physical and Mental Activities in a Rat Model
Ahmed M. Hamdan, Fatimah Hussain J. Alharthi, Ahmed Hadi Alanazi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1008-1008
Open Access | Times Cited: 42
Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis
Cristina de Dios, Xenia Abadin, Vicente Roca‐Agujetas, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation
Kaushiki Biswas
Journal of Neuroimmunology (2023) Vol. 383, pp. 578180-578180
Closed Access | Times Cited: 36
Targeting NLRP3 inflammasome for neurodegenerative disorders
Jing Yao, Zhe Wang, Weihong Song, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4512-4527
Closed Access | Times Cited: 33
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease
Dhanshree Jha, Erik N.T.P. Bakker, Rahul Kumar
Journal of Neurochemistry (2023)
Open Access | Times Cited: 23
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
Cells (2024) Vol. 13, Iss. 17, pp. 1413-1413
Open Access | Times Cited: 8
Oral Administration of Lactobacillus gasseri and Lacticaseibacillus rhamnosus Ameliorates Amyloid Beta (Aβ)-Induced Cognitive Impairment by Improving Synaptic Function Through Regulation of TLR4/Akt Pathway
H Choi, Hyo Lim Lee, In Young Kim, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 139-139
Open Access | Times Cited: 1
Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
Wenjuan Rui, Hong Xiao, Yi Fan, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 51
Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)
Jie Zhou, Ruijie Ma, Ying Jin, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top